Surface exposure of the HIV-1 Env cytoplasmic tail LLP2 domain during the membrane fusion process - Interaction with gp41 fusion core

被引:36
作者
Lu, Lu [2 ]
Zhu, Yun [2 ]
Huang, Jinghe [2 ]
Chen, Xi [2 ]
Yang, Hengwen [2 ]
Jiang, Shibo [1 ]
Chen, Ying-Hua [2 ]
机构
[1] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10065 USA
[2] Tsinghua Univ, Dept Biol, Immunol Lab, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China
关键词
D O I
10.1074/jbc.M801083200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
HIV-1 gp41 cytoplasmic tail (CT) is highly conserved among HIV-1 isolates, particularly the region designated lentivirus lytic peptide (LLP1-2), which includes two alpha-helical domains LLP1 and LLP2. Although the gp41 CT is recognized as a modulator of viral fusogenicity, little is known about the regulatory mechanism of this region in the viral fusion process. Here we report that anti-LLP1-2 and anti-LLP2 antibodies (IgG) inhibited HIV-1 Env-mediated cell fusion and bound to the interface between effector and target cells at a suboptimal temperature (31.5 degrees C), which slows down the fusion process and prolongs the fusion intermediate state. This suggests that LLP1-2, especially the LLP2 region located inside the viral membrane, is transiently exposed on the membrane surface during the fusion process. Synthetic LLP2 peptide could bind to the gp41 six-helix bundle core with high binding affinity. These results suggest that the gp41 CT may interact with the gp41 core, via the surface-exposed LLP2 domain, to regulate Env-mediated membrane fusion.
引用
收藏
页码:16723 / 16731
页数:9
相关论文
共 46 条
[1]   The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle [J].
Abrahamyan, LG ;
Mkrtchyan, SR ;
Binley, J ;
Lu, M ;
Melikyan, GB ;
Cohen, FS .
JOURNAL OF VIROLOGY, 2005, 79 (01) :106-115
[2]   Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41 [J].
Caffrey, M ;
Cai, ML ;
Kaufman, J ;
Stahl, SJ ;
Wingfield, PT ;
Covell, DG ;
Gronenborn, AM ;
Clore, GM .
EMBO JOURNAL, 1998, 17 (16) :4572-4584
[3]   Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles [J].
Celma, CCP ;
Manrique, JM ;
Affranchino, JL ;
Hunter, E ;
González, SA .
VIROLOGY, 2001, 283 (02) :253-261
[4]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[5]   HIV entry and its inhibition [J].
Chan, DC ;
Kim, PS .
CELL, 1998, 93 (05) :681-684
[6]   Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41 [J].
Chen, SSL ;
Lee, SF ;
Wang, CT .
JOURNAL OF VIROLOGY, 2001, 75 (20) :9925-9938
[7]   AN AMPHIPATHIC PEPTIDE FROM THE C-TERMINAL REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN CAUSES PORE FORMATION IN MEMBRANES [J].
CHERNOMORDIK, L ;
CHANTURIYA, AN ;
SUSSTOBY, E ;
NORA, E ;
ZIMMERBERG, J .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7115-7123
[8]   A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion [J].
Cleveland, SM ;
McLain, L ;
Cheung, L ;
Jones, TD ;
Hollier, M ;
Dimmock, NJ .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :591-602
[9]   A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes [J].
Comardelle, AM ;
Norris, CH ;
Plymale, DR ;
Gatti, PJ ;
Choi, B ;
Fermin, CD ;
Haislip, AM ;
Tencza, SB ;
Mietzner, TA ;
Montelaro, RC ;
Garry, RF .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (17) :1525-1532
[10]   Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41:: Implications on viral fusion mechanism [J].
Contreras, LM ;
Aranda, FJ ;
Gavilanes, F ;
González-Ros, JM ;
Villalaín, J .
BIOCHEMISTRY, 2001, 40 (10) :3196-3207